Literature DB >> 25208730

Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.

Carmen Gasca-Salas1, Ainara Estanga2, Pedro Clavero3, Isabel Aguilar-Palacio4, Rafael González-Redondo1, Jose A Obeso1, Maria C Rodríguez-Oroz1.   

Abstract

BACKGROUND: Dementia and mild cognitive impairment (MCI) are frequent in Parkinson's disease (PD). Deficits in some cognitive tests are considered risk factors for dementia in PD. However, how cognitive deficits progress in aged and long-lasting non-demented PD is not known.
OBJECTIVE: To study the rate and pattern of progression of cognitive deficits in aged and long-lasting non-demented PD.
METHODS: Forty-nine non-demented patients (23 cognitively normal (PD-CN) and 26 with MCI (PD-MCI)) were studied over 31 months using individual tests and z-scores covering five cognitive domains. All patients were at least 60 year old and have had PD ≥ 10 years.
RESULTS: Attention, executive function and memory worsened in 5 PD-CN patients who progressed to MCI (21.7% of the sample) and in 1 patient who became demented (4.3% of the sample). Eleven PD-MCI patients who developed dementia (42.3% of the sample) showed aggravation of visuospatial, executive and attention domains. Multidomain-MCI and poor execution of Stroop-Words, copy of intersecting pentagons and Raven Progressive Matrices tests were associated with conversion to dementia.
CONCLUSIONS: This pilot study shows that in long-lasting PD 21.7% of PD-CN patients progress to MCI and 42.3% of PD-MCI progress to dementia over a 31 months observation period. The transition from cognitively normal to MCI is featured by attention, executive and memory dysfunction and the evolution from MCI to dementia is marked by the appearance of visuospatial deficits and worsening of attention and executive function. These data are compatible with the concept that cognitive decline in PD follows a distinct dysfunction pattern with progressive anterior to posterior cortical involvement.

Entities:  

Keywords:  Mild cognitive impairment; Parkinson's disease; dementia; progression

Mesh:

Year:  2014        PMID: 25208730     DOI: 10.3233/JPD-140398

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  12 in total

Review 1.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

2.  Emergent Functional Network Effects in Parkinson Disease.

Authors:  Caterina Gratton; Jonathan M Koller; William Shannon; Deanna J Greene; Baijayanta Maiti; Abraham Z Snyder; Steven E Petersen; Joel S Perlmutter; Meghan C Campbell
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

Review 3.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

Review 4.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

5.  Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.

Authors:  Carmen Gasca-Salas; Pedro Clavero; David García-García; José A Obeso; María C Rodríguez-Oroz
Journal:  Hum Brain Mapp       Date:  2015-12-14       Impact factor: 5.038

6.  Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.

Authors:  Meghan C Campbell; Joshua J Jackson; Jonathan M Koller; Abraham Z Snyder; Paul T Kotzbauer; Joel S Perlmutter
Journal:  Neurology       Date:  2019-12-18       Impact factor: 9.910

7.  Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease.

Authors:  Baijayanta Maiti; Jonathan M Koller; Abraham Z Snyder; Aaron B Tanenbaum; Scott A Norris; Meghan C Campbell; Joel S Perlmutter
Journal:  Neurology       Date:  2019-12-17       Impact factor: 9.910

8.  The correlation between possible RBD and cognitive function in Parkinson's disease patients in China.

Authors:  Ya-Yun Yan; Ke Lei; Yuan-Yuan Li; Xiu-Feng Liu; Ying Chang
Journal:  Ann Clin Transl Neurol       Date:  2019-04-13       Impact factor: 4.511

9.  Multivariate prediction of dementia in Parkinson's disease.

Authors:  Thanaphong Phongpreecha; Brenna Cholerton; Ignacio F Mata; Cyrus P Zabetian; Kathleen L Poston; Nima Aghaeepour; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Karen L Edwards; Thomas J Montine
Journal:  NPJ Parkinsons Dis       Date:  2020-08-25

10.  Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat.

Authors:  Mounia Rahmani; Maria Benabdeljlil; Fouad Bellakhdar; Mustapha El Alaoui Faris; Mohamed Jiddane; Khalil El Bayad; Fatima Boutbib; Rachid Razine; Rachid Gana; Moulay R El Hassani; Nizar El Fatemi; Meryem Fikri; Siham Sanhaji; Hennou Tassine; Imane El Alaoui Balrhiti; Souad El Hadri; Najwa Ech-Cherif Kettani; Najia El Abbadi; Mourad Amor; Abdelmjid Moussaoui; Afifa Semlali; Saadia Aidi; El Hachmia Ait Benhaddou; Ali Benomar; Ahmed Bouhouche; Mohamed Yahyaoui; Abdeslam El Khamlichi; Abdessamad El Ouahabi; Rachid El Maaqili; Houyam Tibar; Yasser Arkha; Adyl Melhaoui; Abdelhamid Benazzouz; Wafa Regragui
Journal:  Front Neurol       Date:  2018-07-31       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.